814 related articles for article (PubMed ID: 35361161)
21. Variation in Clinical Treatment and Outcomes by Race Among US Veterans Hospitalized With COVID-19.
Castro AD; Mayr FB; Talisa VB; Shaikh OS; Omer SB; Yende S; Butt AA
JAMA Netw Open; 2022 Oct; 5(10):e2238507. PubMed ID: 36282499
[TBL] [Abstract][Full Text] [Related]
22. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.
Maximiano Sousa F; Roelens M; Fricker B; Thiabaud A; Iten A; Cusini A; Flury D; Buettcher M; Zukol F; Balmelli C; Zimmermann P; Troillet N; Vuichard-Gysin D; Schreiber PW; Bernhard-Stirnemann S; Tschudin-Sutter S; Nussbaumer-Ochsner Y; Sommerstein R; Gaudenz R; Marschall J; Senn L; Gardiol C; Keiser O; Schüpbach G; Wymann M; Vidondo B; Ch-Sur Study Group
Swiss Med Wkly; 2021 Jul; 151():w20547. PubMed ID: 34324698
[TBL] [Abstract][Full Text] [Related]
24. Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults.
Surie D; Yuengling KA; DeCuir J; Zhu Y; Lauring AS; Gaglani M; Ghamande S; Peltan ID; Brown SM; Ginde AA; Martinez A; Mohr NM; Gibbs KW; Hager DN; Ali H; Prekker ME; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Leis AM; Khan A; Hough CL; Bender WS; Duggal A; Bendall EE; Wilson JG; Qadir N; Chang SY; Mallow C; Kwon JH; Exline MC; Shapiro NI; Columbus C; Vaughn IA; Ramesh M; Mosier JM; Safdar B; Casey JD; Talbot HK; Rice TW; Halasa N; Chappell JD; Grijalva CG; Baughman A; Womack KN; Swan SA; Johnson CA; Lwin CT; Lewis NM; Ellington S; McMorrow ML; Martin ET; Self WH;
JAMA Netw Open; 2024 Apr; 7(4):e244954. PubMed ID: 38573635
[TBL] [Abstract][Full Text] [Related]
25. Risk factors associated with intensive care unit (ICU) admission and in-hospital death among adults hospitalized with COVID-19: a two-center retrospective observational study in tertiary care hospitals.
Shayganfar A; Sami R; Sadeghi S; Dehghan M; Khademi N; Rikhtehgaran R; Basiratnia R; Ferdosi F; Hajiahmadi S
Emerg Radiol; 2021 Aug; 28(4):691-697. PubMed ID: 33534017
[TBL] [Abstract][Full Text] [Related]
26. Clinical Characteristics and Outcomes of Patients Hospitalized With COVID-19 During the First 4 Waves in Zambia.
Minchella PA; Chanda D; Hines JZ; Fwoloshi S; Itoh M; Kampamba D; Chirwa R; Sivile S; Zyambo KD; Agolory S; Mulenga LB
JAMA Netw Open; 2022 Dec; 5(12):e2246152. PubMed ID: 36512359
[TBL] [Abstract][Full Text] [Related]
27. Vaccination status and outcomes of COVID-19 patients admitted to a tertiary hospital in Iran during the dominant Delta variant period.
Mehdinezhad H; Karim B; Ahmadi N; Ahangar RM; Asadolahzadeh A; Haddad-Zavareh MS; Khoshkhou F; Qolami Z; Gorji NM; Delavar MA
Immun Inflamm Dis; 2023 Feb; 11(2):e790. PubMed ID: 36840484
[TBL] [Abstract][Full Text] [Related]
28. Not all COVID-19 pandemic waves are alike.
Domingo P; Pomar V; Mur I; Castellví I; Corominas H; de Benito N
Clin Microbiol Infect; 2021 Jul; 27(7):1040.e7-1040.e10. PubMed ID: 33887469
[TBL] [Abstract][Full Text] [Related]
29. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
30. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study.
Nikpouraghdam M; Jalali Farahani A; Alishiri G; Heydari S; Ebrahimnia M; Samadinia H; Sepandi M; Jafari NJ; Izadi M; Qazvini A; Dorostkar R; Tat M; Shahriary A; Farnoosh G; Hosseini Zijoud SR; Taghdir M; Alimohamadi Y; Abbaszadeh S; Gouvarchin Ghaleh HE; Bagheri M
J Clin Virol; 2020 Jun; 127():104378. PubMed ID: 32353762
[TBL] [Abstract][Full Text] [Related]
31. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
[TBL] [Abstract][Full Text] [Related]
32. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
Wang D; Hu B; Hu C; Zhu F; Liu X; Zhang J; Wang B; Xiang H; Cheng Z; Xiong Y; Zhao Y; Li Y; Wang X; Peng Z
JAMA; 2020 Mar; 323(11):1061-1069. PubMed ID: 32031570
[TBL] [Abstract][Full Text] [Related]
33. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
34. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.
Al-Salameh A; Lanoix JP; Bennis Y; Andrejak C; Brochot E; Deschasse G; Dupont H; Goeb V; Jaureguy M; Lion S; Maizel J; Moyet J; Vaysse B; Desailloud R; Ganry O; Schmit JL; Lalau JD
Diabetes Metab Res Rev; 2021 Mar; 37(3):e3388. PubMed ID: 32683744
[TBL] [Abstract][Full Text] [Related]
35. In-hospital mortality of COVID-19 in Iranian children and youth: A multi-centre retrospective cohort study.
Fattahi P; Abdi S; Saeedi E; Sirous S; Firuzian F; Mohammadi M; Taheri N; Khaki M; Qandian A; Lotfi F; Iranmehr A; Nemati S; Rajabpour MV
J Glob Health; 2022 Nov; 12():05048. PubMed ID: 36370421
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for ventilator-associated lower respiratory tract infection in COVID-19, a retrospective multicenter cohort study in Sweden.
Forsberg G; Taxbro K; Elander L; Hanberger H; Berg S; Idh J; Berkius J; Ekman A; Hammarskjöld F; Niward K; Balkhed ÅÖ
Acta Anaesthesiol Scand; 2024 Feb; 68(2):226-235. PubMed ID: 37751991
[TBL] [Abstract][Full Text] [Related]
37. Multiparametric correlation of laboratory biomarkers to multiorgan failure outcome in hospitalized COVID-19 patients: a retrospective observational study.
Ballini A; Cantore S; Serretiello E; Troiano G; Smimmo A; Dioguardi M; Spirito F; Sasso FC; De Vito D; Lo Muzio L; Di Domenico M
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8962-8974. PubMed ID: 37782206
[TBL] [Abstract][Full Text] [Related]
38. Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities.
Alser O; Mokhtari A; Naar L; Langeveld K; Breen KA; El Moheb M; Kapoen C; Gaitanidis A; Christensen MA; Maurer LR; Mashbari H; Bankhead-Kendall B; Parks J; Fawley J; Saillant N; Mendoza A; Paranjape C; Fagenholz P; King D; Lee J; Farhat MR; Velmahos GC; Kaafarani HMA
J Trauma Acute Care Surg; 2021 May; 90(5):880-890. PubMed ID: 33891572
[TBL] [Abstract][Full Text] [Related]
39. Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.
Bennett TD; Moffitt RA; Hajagos JG; Amor B; Anand A; Bissell MM; Bradwell KR; Bremer C; Byrd JB; Denham A; DeWitt PE; Gabriel D; Garibaldi BT; Girvin AT; Guinney J; Hill EL; Hong SS; Jimenez H; Kavuluru R; Kostka K; Lehmann HP; Levitt E; Mallipattu SK; Manna A; McMurry JA; Morris M; Muschelli J; Neumann AJ; Palchuk MB; Pfaff ER; Qian Z; Qureshi N; Russell S; Spratt H; Walden A; Williams AE; Wooldridge JT; Yoo YJ; Zhang XT; Zhu RL; Austin CP; Saltz JH; Gersing KR; Haendel MA; Chute CG;
JAMA Netw Open; 2021 Jul; 4(7):e2116901. PubMed ID: 34255046
[TBL] [Abstract][Full Text] [Related]
40. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
Simpson-Yap S; De Brouwer E; Kalincik T; Rijke N; Hillert JA; Walton C; Edan G; Moreau Y; Spelman T; Geys L; Parciak T; Gautrais C; Lazovski N; Pirmani A; Ardeshirdavanai A; Forsberg L; Glaser A; McBurney R; Schmidt H; Bergmann AB; Braune S; Stahmann A; Middleton R; Salter A; Fox RJ; van der Walt A; Butzkueven H; Alroughani R; Ozakbas S; Rojas JI; van der Mei I; Nag N; Ivanov R; Sciascia do Olival G; Dias AE; Magyari M; Brum D; Mendes MF; Alonso RN; Nicholas RS; Bauer J; Chertcoff AS; Zabalza A; Arrambide G; Fidao A; Comi G; Peeters L
Neurology; 2021 Nov; 97(19):e1870-e1885. PubMed ID: 34610987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
